Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Fresenius Medical Care AG (FMS)

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/17/1996

Market Cap

11,167,298,780

Shares Outstanding

293,410,000

Weighted SO

586,826,898

Total Employees

N/A

Upcoming Earnings

08/07/2024

Beta

0.8620

Last Div

0.6400

Range

16.37-24.48

Chg

0.3500

Avg Vol

347335

Mkt Cap

11167298780

Exch

NYSE

Country

DE

Phone

49 6172 608 2522

DCF Diff

-32.2938

DCF

51.3838

Div Yield

0.0362

P/S

0.5220

EV Multiple

6.6035

P/FV

0.3637

Div Yield %

3.6170

P/E

9.5562

PEG

3.4045

Payout

0.6585

Current Ratio

1.4640

Quick Ratio

1.0887

Cash Ratio

0.1837

DSO

76.3673

DIO

56.0850

Op Cycle

132.4523

DPO

19.7323

CCC

112.7200

Gross Margin

0.2534

Op Margin

0.0687

Pretax Margin

0.0511

Net Margin

0.0273

Eff Tax Rate

0.3162

ROA

0.0156

ROE

0.0374

ROCE

0.0477

NI/EBT

0.5349

EBT/EBIT

0.7437

EBIT/Rev

0.0687

Debt Ratio

0.2441

D/E

0.5939

LT Debt/Cap

0.3297

Total Debt/Cap

0.3726

Int Coverage

3.2848

CF/Debt

0.2476

Equity Multi

2.4330

Rec Turnover

4.7795

Pay Turnover

18.4976

Inv Turnover

6.5080

FA Turnover

2.6737

Asset Turnover

0.5728

OCF/Share

6.9818

FCF/Share

4.6433

Cash/Share

3.7156

OCF/Sales

0.1055

FCF/OCF

0.6651

CF Coverage

0.2476

ST Coverage

1.4430

CapEx Coverage

2.9856

Div&CapEx Cov

1.9787

P/BV

0.3637

P/B

0.3637

P/S

0.5220

P/E

9.5562

P/FCF

7.4387

P/OCF

2.4736

P/CF

2.4736

PEG

3.4045

P/S

0.5220

EV Multiple

6.6035

P/FV

0.3637

DPS

0.6883

Latest Headlines (EST)

GlobeNewswire Inc. Dec 05, 00:30 Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology Benzinga Dec 05, 00:30 Hemodialysis and Peritoneal Dialysis Market to Surpass Valuation of USD 142.97 Billion by 2031 | SkyQuest Technology GlobeNewswire Inc. Jan 16, 08:31 Foremost Lithium to Present at Cambridge House Vancouver Resource Investment Conference GlobeNewswire Inc. Jan 10, 08:31 Foremost Lithium Receives Multi-Year Work Permit to Commence Drilling on its Jean Lake Lithium/Gold Property GlobeNewswire Inc. Jan 04, 08:31 Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF) GlobeNewswire Inc. Dec 28, 08:31 Foremost Lithium Announces a 7,500 Metre Winter Drill Program on Its Zoro Lithium Property GlobeNewswire Inc. Dec 19, 08:31 Foremost Lithium Announces Winter Drilling Plans on Its Jean Lake Lithium/Gold Property GlobeNewswire Inc. Dec 12, 08:31 Foremost Lithium Issues Shareholder Letter and Provides Corporate Update GlobeNewswire Inc. Dec 04, 08:31 Foremost Lithium Appoints Douglas L. Mason to Board of Directors GlobeNewswire Inc. Nov 13, 08:31 Foremost Lithium Engages Outside the Box Capital for Digital Marketing Services MarketWatch Nov 10, 11:13 Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.69 05/17/2024 04/15/2024 05/20/2024 06/03/2024
0.67 05/17/2023 05/03/2023 05/18/2023 06/01/2023
0.74 05/13/2022 04/28/2022 05/16/2022 05/27/2022
0.83 05/24/2021 05/17/2021 05/25/2021 06/07/2021
0.84 08/28/2020 08/12/2020 08/31/2020 09/11/2020
0.66 05/17/2019 05/08/2019 05/20/2019 05/31/2019
0.63 05/21/2018 05/10/2018 05/22/2018 06/04/2018
0.51 05/11/2017 04/24/2017 05/15/2017 05/26/2017
0.44 05/10/2016 03/09/2016 05/12/2016 05/23/2016
0.44 05/15/2015 11/30/-0001 11/30/-0001 06/01/2015
0.73 05/13/2014 05/02/2014 05/15/2014 05/27/2014
0.49 05/14/2013 05/14/2013 05/16/2013 05/28/2013
1.18 05/08/2012 11/30/-0001 11/30/-0001 05/21/2012
1.35 05/10/2011 11/30/-0001 11/30/-0001 05/23/2011
1.04 05/07/2010 11/30/-0001 11/30/-0001 11/30/-0001
1.01 05/05/2009 11/30/-0001 11/30/-0001 11/30/-0001
1.29 05/16/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.85 05/11/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.62 05/05/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.60 05/20/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.51 05/25/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.10 05/20/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.39 05/20/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.23 05/20/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.21 05/21/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.20 05/25/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.22 05/28/1999 11/30/-0001 11/30/-0001 11/30/-0001
0.20 06/08/1998 11/30/-0001 11/30/-0001 11/30/-0001